Brief: Sonnet Biotherapeutics Initiates Manufacturing Process For SON-1410
31/08/2021 14:36
Aug 31 (Reuters) - Sonnet Biotherapeutics Holdings Inc
SONN.O :
* SONNET BIOTHERAPEUTICS - INITIATING MANUFACTURING PROCESS
FOR
SON-1410 WITH CELL LINE & PROCESS DEVELOPMENT, INTENDS TO FILE
IND DURING H2 2022
Source text for Eikon: [https://bit.ly/3kFeLHV]
Further company coverage: SONN.O
((Reuters.Briefs@thomsonreuters.com;))